EOFlow Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Employees
  • 63

Employees

  • Stock Symbol
  • 294090

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $1.01
  • (As of Friday Closing)

EOFlow General Information

Description

EOFlow Co Ltd is an operator of a wearable disposable drug delivery platform that manufactures wearable insulin pumps and other related products in South Korea.

Contact Information

Website
www.eoflow.com
Formerly Known As
Nephria Bio
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 25, Gyeongchung-daero 295beon-gil, Gonjiam-eup
  • Gonjiam-eup
  • Gwangju, Gyeonggi 12813
  • South Korea
+82
Primary Industry
Drug Delivery
Other Industries
Other Healthcare Technology Systems
Therapeutic Devices
Stock Exchange
KRX
Corporate Office
  • 25, Gyeongchung-daero 295beon-gil, Gonjiam-eup
  • Gonjiam-eup
  • Gwangju, Gyeonggi 12813
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EOFlow Stock Performance

As of 21-Mar-2025, EOFlow’s stock price is $1.01. Its current market cap is $30.9M with 30.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.01 $1.07 $0.99 - $13.55 $30.9M 30.4M 1.19M -$1.55

EOFlow Financials Summary

As of 30-Jun-2026, EOFlow has a trailing 12-month revenue of $1.37M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 82,423 89,936
Revenue 1,375 2,579 3,841 5,040
EBITDA 56,515 (16,207) (136,071) (39,330)
Net Income 42,591 (29,726) (139,217) (47,371)
Total Assets 20,098 25,261 33,284 62,613
Total Debt 14,437 13,665 22,590 11,417
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EOFlow Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EOFlow‘s full profile, request access.

Request a free trial

EOFlow Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
EOFlow Co Ltd is an operator of a wearable disposable drug delivery platform that manufactures wearable insulin pumps an
Drug Delivery
Gwangju, South Korea
63 As of 2025

San Diego, CA
 

Acton, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EOFlow Competitors (2)

One of EOFlow’s 2 competitors is Tandem Diabetes Care, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tandem Diabetes Care Formerly VC-backed San Diego, CA
Insulet Formerly VC-backed Acton, MA
You’re viewing 2 of 2 competitors. Get the full list »

EOFlow Patents

EOFlow Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026059033-A1 Method, device, and program for adjusting insulin injection amount based on predicted blood glucose Pending 12-Sep-2024
WO-2025264049-A1 Liquid medicine injection device Pending 21-Jun-2024
WO-2025014075-A1 System for injecting multiple medical liquids Inactive 10-Jul-2023
WO-2024232690-A1 Liquid medicine injection device Inactive 09-May-2023
WO-2024225542-A1 Liquid medicine injection device Inactive 24-Apr-2023 A61M5/14248
To view EOFlow’s complete patent history, request access »

EOFlow Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EOFlow Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore EOFlow‘s full profile, request access.

Request a free trial

EOFlow Investments (4)

EOFlow’s most recent deal was a Later Stage VC with Biolinq for . The deal was made on 17-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Biolinq 17-Oct-2022 Later Stage VC Monitoring Equipment
SINOFLOW Company 26-Jan-2022 Joint Venture Therapeutic Devices
DS Techno (4,850 Square Meter Land and 1,523.28 Square Meter Building in Gwangju, South Korea) 30-Jun-2021 Corporate Asset Purchase Buildings and Property
SanPlena 01-Jan-2021 Joint Venture Drug Discovery
To view EOFlow’s complete investments history, request access »

EOFlow ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

32.54 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Technology Hardware

Industry

of 556

Rank

Percentile

Electronics Equipment

Subindustry

of 106

Rank

Percentile

To view EOFlow’s complete esg history, request access »

EOFlow Exits (1)

EOFlow’s most recent exit was on 01-Jan-2021 from SanPlena. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
SanPlena 01-Jan-2021 Completed
  • 2 buyers
To view EOFlow’s complete exits history, request access »

EOFlow FAQs

  • When was EOFlow founded?

    EOFlow was founded in 2011.

  • Where is EOFlow headquartered?

    EOFlow is headquartered in Gwangju, South Korea.

  • What is the size of EOFlow?

    EOFlow has 63 total employees.

  • What industry is EOFlow in?

    EOFlow’s primary industry is Drug Delivery.

  • Is EOFlow a private or public company?

    EOFlow is a Public company.

  • What is EOFlow’s stock symbol?

    The ticker symbol for EOFlow is 294090.

  • What is the current stock price of EOFlow?

    As of 21-Mar-2025 the stock price of EOFlow is $1.01.

  • What is the current market cap of EOFlow?

    The current market capitalization of EOFlow is $30.9M.

  • What is EOFlow’s current revenue?

    The trailing twelve month revenue for EOFlow is $1.37M.

  • Who are EOFlow’s competitors?

    Tandem Diabetes Care and Insulet are competitors of EOFlow.

  • What is EOFlow’s annual earnings per share (EPS)?

    EOFlow’s EPS for 12 months was -$1.55.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process